{
  "author": {
    "name": "Makiko Kitamura",
    "webUrl": "/author/profile/makiko-kitamura/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 3,
    "social": [],
    "articles": [
      {
        "uri": "/2015/01/28/anthem-expects-higher-earnings/",
        "title": "Anthem expects higher earnings",
        "byline": "Doni Bloomfield, Makiko Kitamura",
        "kicker": "",
        "prettyDate": "January 28, 2015",
        "timeToRead": "1 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/doni-bloomfield-makiko-kitamura/",
            "name": "Doni Bloomfield, Makiko Kitamura"
          }
        ],
        "kickerNode": [],
        "summary": "Anthem said profit will rise this year on growing enrollment of new customers.",
        "body": null
      },
      {
        "uri": "/2014/08/06/walgreen-backs-down/",
        "title": "Walgreen backs down",
        "byline": "Cynthia Koons, Makiko Kitamura",
        "kicker": "",
        "prettyDate": "August 06, 2014",
        "timeToRead": "4 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/cynthia-koons-makiko-kitamura/",
            "name": "Cynthia Koons, Makiko Kitamura"
          }
        ],
        "kickerNode": [],
        "summary": "Walgreen Co., the biggest U.S. drugstore chain, said it plans to buy all of Alliance Boots for about $15.3 billion and wont use the deal to move its tax address abroad.",
        "body": null
      },
      {
        "uri": "/2014/04/15/heart-drug-costs-millions-more-as-generic-held-bac/",
        "title": "Heart drug costs millions more as generic held back",
        "byline": "Makiko Kitamura",
        "kicker": "",
        "prettyDate": "April 15, 2014",
        "timeToRead": "6 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/makiko-kitamura/",
            "name": "Makiko Kitamura"
          }
        ],
        "kickerNode": [],
        "summary": "A gap in U.S. patent law has kept cheap copies of Novartis AGs heart drug Diovan off the market for 18 months, costing consumers and insurers as much as $900 million in potential savings.",
        "body": null
      }
    ]
  }
}